MitoTam bromide, hydrobromide is a tamoxifen derivative that acts as an electron transport chain (ETC) inhibitor, suppressing mitochondrial membrane potential changes and altering mitochondrial morphology in senescent cells; it is a potent anticancer agent that inhibits CI-respiration and supercomplex (SC) formation in breast cancer cells.